High productivity in bioprocess development demands efficient bioanalytical procedures to measure, for example, product titer and process impurities, but commonly used methods, such as enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography, can create bottlenecks in critical workflows.
Gyros’ open nanoliter-scale immunoassay platform improves productivity in bioanalytical workflows by providing rapid assay development time, automation, high throughput, and a broad dynamic range that minimizes dilutions and repeats.
Gyrolab™ systems (Gyrolab™ xP and Gyrolab xPlore™) have been implemented in many bioprocess development labs and are routinely used to determine:
IgG product titer during clone selection and cell culture development
Host Cell Proteins and Leached Protein A impurities during downstream purification processes